Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,874 | -52,739 | -38,845 | -24,409 | -6,450 |
| Depreciation Amortization | 4,701 | 6,440 | 2,982 | 1,887 | 958 |
| Accounts receivable | 1,394 | -1,357 | -674 | -251 | -270 |
| Accounts payable and accrued liabilities | -626 | -993 | -2,585 | -738 | -1,618 |
| Other Working Capital | -10,411 | -18,577 | -17,555 | -21,782 | -17,598 |
| Other Operating Activity | -4 | 12,978 | 13,454 | 10,073 | 5,162 |
| Operating Cash Flow | $-15,820 | $-54,248 | $-43,223 | $-35,220 | $-19,816 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,548 | 67,461 | 64,051 | 45,911 | 25,574 |
| PPE Investments | 928 | -12,751 | -12,692 | -11,833 | -7,754 |
| Investing Cash Flow | $-3,620 | $54,710 | $51,359 | $34,078 | $17,820 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 10,000 | 8,612 | N/A | N/A |
| Debt Repayment | -2,757 | -7,785 | -7,785 | -6,352 | -2,524 |
| Common Stock Issued | 4,426 | 191 | 191 | 30 | 29 |
| Other Financing Activity | 0 | -1,388 | 0 | 0 | 0 |
| Financing Cash Flow | $1,669 | $1,018 | $1,018 | $-6,322 | $-2,495 |
| Beginning Cash Position | 52,306 | 50,826 | 50,826 | 50,826 | 50,826 |
| End Cash Position | 34,535 | 52,306 | 59,980 | 43,362 | 46,335 |
| Net Cash Flow | $-17,771 | $1,480 | $9,154 | $-7,464 | $-4,491 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,820 | -54,248 | -43,223 | -35,220 | -19,816 |
| Capital Expenditure | N/A | -12,942 | -12,875 | -11,833 | -7,754 |
| Free Cash Flow | -15,820 | -67,190 | -56,098 | -47,053 | -27,570 |